Back to Journals » Journal of Pain Research » Volume 7

Fasinumab (REGN475), an antinerve growth factor monoclonal antibody, for the treatment of acute sciatic pain: results of a proof-of-concept study

Total article views   HTML views PDF downloads Totals
18,141 Dovepress* 14,506+ 1,951 16,457
PubMed Central* 3,635 746 4,381
Totals 18,141 2,697 20,838
*Since 22 August 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 0 8

View citations on PubMed Central and Google Scholar